| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040606 Reducing immunogenicities of immunoglobulins by framework-patching |
| 02/27/2003 | US20030040471 For stimulating keratinocyte growth and motility; for inhibiting the growth of cancer cells; for modulating angiogenesis for modulating skin inflammation; for stimulating the growth of epithelial cells |
| 02/27/2003 | US20030040463 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects |
| 02/27/2003 | US20030040099 Nucleotide sequences coding polypeptide for use the generating vaccine for treatment and prevention of viral diseases |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030040046 Netrin receptors |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
| 02/27/2003 | US20030039680 Buccal, polar and non-polar spray or capsule |
| 02/27/2003 | US20030039667 Anti-fungal composition |
| 02/27/2003 | US20030039666 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/27/2003 | US20030039665 Inducing immunology response; administering by nose |
| 02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039660 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 02/27/2003 | US20030039657 DNA sequences encoding polypeptides of pathogens and antigens and an additional DNA sequence encoding a regulatory moiety which can bind with an administered activating agent to induce expression of an immune response |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039653 Identifying a mammal with, or at risk of developing, cancer; cells of the cancer are identified as expressing B7-H1 molecules on their surfaces, and administering an agent that interferes with interaction between B7-H1 and t-cells |
| 02/27/2003 | US20030039650 Adminstering t-cells that have been isolated and expanded ex vivo from a patient with an immune imbalance back into the patient |
| 02/27/2003 | US20030039649 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
| 02/27/2003 | US20030039648 Compositions and methods for the diagnosis and treatment of tumor |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039641 Cells expressing anti-fc receptor binding components |
| 02/27/2003 | US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 02/27/2003 | US20030039635 Compositions and methods for WT1 specific immunotherapy |
| 02/27/2003 | US20030039628 Treating cancer or viral diseases for enhancing T-cell proliferation by administering an effective amount compound that inhibits the production or release of intercellular reactive oxygen metabolites |
| 02/27/2003 | US20030039611 Selectively binds to antigen to cause cell impairment |
| 02/27/2003 | US20030039505 Document folder |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457595A1 A method of producing antibodies ex-vivo |
| 02/27/2003 | CA2457461A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 02/27/2003 | CA2457330A1 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | CA2457328A1 Agents for enhancing the immune response |
| 02/27/2003 | CA2457163A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | CA2457143A1 In situ immunization |
| 02/27/2003 | CA2457008A1 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456201A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 02/27/2003 | CA2456149A1 Recombinant conjugate polypeptides for photodynamic therapy |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454853A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2452104A1 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 02/27/2003 | CA2451998A1 Anti-a.beta. antibodies |
| 02/27/2003 | CA2423025A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 02/26/2003 | WO2002017961A1 Vaccine preparation containing fatty acid as component |
| 02/26/2003 | EP1285960A2 Virulence genes from Salmonella typhimurium |
| 02/26/2003 | EP1285930A2 Human antibodies that bind human TNFalpha |
| 02/26/2003 | EP1285666A1 Salmonella typhi vaccine compositions |
| 02/26/2003 | EP1285271A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 02/26/2003 | EP1285270A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285079A2 Modified bovine adenovirus having altered tropism |
| 02/26/2003 | EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/26/2003 | EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 02/26/2003 | EP1285067A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 02/26/2003 | EP1285059A2 Adjuvant preparation for the induction of specific immunity |
| 02/26/2003 | EP1285002A2 REGULATING LIPID LEVELS VIA THE i ZMAX1 /i OR i HBM /i GENE |
| 02/26/2003 | EP1284998A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 02/26/2003 | EP1284997A2 Therapeutic compounds for ovarian cancer |
| 02/26/2003 | EP1284996A2 Therapeutic anti-melanoma compounds |
| 02/26/2003 | EP1284995A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 02/26/2003 | EP1284993A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 02/26/2003 | EP1284986A1 Javelinization of protein antigens to heat shock proteins |
| 02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
| 02/26/2003 | EP1284751A1 Compositions and methods for induction of active autoimmunity |
| 02/26/2003 | EP1284747A2 Compositions and methods for achieving immune suppression |
| 02/26/2003 | EP1284720A2 Method of treating hepatitis delta viral infection |
| 02/26/2003 | EP0910407B1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/26/2003 | EP0768893B1 Polynucleotide vaccine for papillomavirus |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0436717B1 System for use in a method of therapeutic or diagnostic treatment |
| 02/26/2003 | CN1399722A Compositions and Methods for detecting treponema pallidum |
| 02/26/2003 | CN1399675A Method of proliferating natural killer cells |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399556A APRIL receptor (BCMA) and uses thereof |
| 02/26/2003 | CN1399554A Method and compositions for inhibiting adhesion formation |
| 02/26/2003 | CN1399539A Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 02/26/2003 | CN1398973A Liver cancer targeting hepatitis B antisense RNA expression vector and its construction process and use |
| 02/26/2003 | CN1398965A Type-O hoof-and-mouth disease virus, type-O hoof-and-mouth disease vaccine with the virus and active component and the prepn of the vaccine |
| 02/26/2003 | CN1398638A Preparation of tick-borne encephalitis resisting vaccine |
| 02/26/2003 | CA2420601A1 Vaccine preparation containing fatty acid as component |
| 02/25/2003 | US6525242 Preparation of non-human animals having chimeric livers for use of animal models for human liver toxins; immunocompetent animals are rendered tolerant to human hepatocytes by cell or lysate administration during embryonic or neonate stage |
| 02/25/2003 | US6525187 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/25/2003 | US6525186 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525177 Truncated forms of NY-ESO-1 protein |
| 02/25/2003 | US6525173 To be used in diagnosis of acquired immunodeficiency disease virus (AIDS), vaccination, antibody production or in research |
| 02/25/2003 | US6524855 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 02/25/2003 | US6524840 Polynucleotides, host cell expression systems, the encoded proteins, polypeptides and peptides |